Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an electrolyte that plays a crucial role in numerous biochemical functions, including neuromuscular transmission, cardiac excitability, and enzyme activity.
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of seizures in preeclampsia and eclampsia.
* Management of torsades de pointes.
* Treatment of severe asthma exacerbations (off-label).
* Management of status epilepticus (off-label).
## Adult Dosing
* **Hypomagnesemia:**
* Intravenous (IV): 40-80 mEq (1.6-3.2 g elemental Mg) infused over 5-60 minutes, followed by 20 mEq (0.8 g elemental Mg) in 1 L of IV fluid at a rate of 2-10 mEq/hour.
* Intramuscular (IM): 1-4 g (8-32 mEq elemental Mg) every 4-6 hours for 3-4 doses.
* **Preeclampsia/Eclampsia:**
* Loading dose: 4-6 g IV infused over 5-20 minutes.
* Maintenance dose: 1-2 g/hour IV infusion. Specific protocols may vary, often guided by clinical response and serum magnesium levels.
* **Torsades de Pointes:** 1-2 g IV in 50-100 mL D5W over 10 minutes, followed by 0.5-1 g/hour infusion.
* **Status Epilepticus (off-label):** 1-2 g IV over 5-10 minutes.
## Pediatric Dosing
* **Hypomagnesemia:**
* IV: 25-50 mg/kg/dose (elemental Mg), maximum 2 g, infused over 10-30 minutes. May be repeated every 4-12 hours. Follow with maintenance infusion of 20-30 mg/kg/day (elemental Mg).
* **Eclampsia (off-label):** Dosing is complex and often guided by expert consensus or institutional protocols. Typically involves a loading dose followed by a continuous infusion. Consult pediatric critical care guidelines.
* **Status Epilepticus (off-label):** 25-50 mg/kg/dose (elemental Mg) IV, maximum 2 g, infused over 10-30 minutes.
## Dose Adjustments
* **Renal Impairment:** Use with caution. Reduce dose in patients with impaired renal function, as magnesium is renally excreted. Monitor serum magnesium levels closely.
## Contraindications
* Hypermagnesemia.
* Heart block.
* Myocardial infarction (absolute contraindication may depend on specific clinical scenario and alternative options).
* Severe renal impairment.
## Adverse Effects
* **Common:** Flushing, sweating, hypotension, nausea, vomiting, lethargy, decreased deep tendon reflexes.
* **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (muscle weakness, decreased reflexes, ECG changes, bradycardia, hypotension, respiratory arrest, cardiac arrest).
## Key Drug Interactions
* **Neuromuscular Blockers:** Potentiates neuromuscular blockade, increasing the risk of prolonged paralysis and respiratory depression.
* **Calcium Channel Blockers:** Increased risk of hypotension and bradycardia.
* **Tetracyclines and Bisphosphonates:** Magnesium can decrease the absorption of these drugs. Administer at least 2-3 hours apart.
## Monitoring
* **Serum Magnesium Levels:** Essential, especially with IV infusions, renal impairment, and in pediatric patients. Therapeutic range is typically 1.7-2.6 mEq/L (or 4-6.5 mg/dL). Toxicity is a concern above 4 mEq/L.
* **Renal Function:** Monitor creatinine and BUN.
* **Vital Signs:** Blood pressure, heart rate, respiratory rate.
* **Deep Tendon Reflexes:** Assess for loss of reflexes, an early sign of toxicity.
* **Urine Output:** Ensure adequate renal function.
## Clinical Pearls
* Magnesium sulfate is administered as elemental magnesium. Pay close attention to the mEq or gram elemental magnesium content when calculating doses.
* Rapid IV infusion can cause hypotension and flushing. Infuse as recommended.
* In cases of eclampsia, monitoring reflexes and respiratory rate is critical due to the risk of magnesium toxicity.
* IV magnesium should be administered with continuous cardiac monitoring.
* Calcium gluconate or calcium chloride is the antidote for magnesium sulfate toxicity.
***
**Disclaimer:** This information is intended for clinical professionals. Always consult the most current prescribing information and institutional protocols for definitive guidance. Dosing and indications can vary based on patient-specific factors and evolving medical knowledge.
